ACCURAY INC (ARAY) Latest Company News

Oct 13, 2026, 20:15 UTC
ACCURAY INC reported that Class II director Mika Nishimura departed following the expiration of her term.
Oct 6, 2026, 20:14 UTC
ACCURAY INC appointed Richard A. Meier as a Class II director and member of its Compensation Committee.
Oct 6, 2026, 20:10 UTC
Accuray stockholders approved all proposals presented at the company’s special meeting, enabling the company to complete previously announced transactions with TCW Asset Management Company.
Source:
- prnewswire.com
Sep 27, 2026, 15:15 UTC
Accuray Incorporated entered into agreements with Samsung HME America, Inc. (dba NeuroLogica Corp.) to pursue advanced volumetric imaging capabilities for the Accuray CyberKnife System.
Source:
- prnewswire.com
Sep 11, 2026, 15:28 UTC
Accuray Incorporated and RaySearch Laboratories AB entered into a definitive agreement for an expanded collaboration to integrate RayStation software with Accuray platforms and accelerate Accuray's online adaptive radiation therapy capabilities.
Source:
- prnewswire.com
Aug 19, 2026, 00:00 UTC
Accuray Inc reported Q4 2026 revenue of $100.9 million, down 21% year-over-year, with a net loss of $1.9 million and diluted EPS of -$0.02.
Source:
- prnewswire.com
- seekingalpha.com
Aug 12, 2026, 21:09 UTC
Accuray Incorporated announced two key executive leadership appointments to improve operational execution and profitability as part of its transformation plan.
Source:
- prnewswire.com
Aug 6, 2026, 00:00 UTC
Accuray Inc. received a notice from NASDAQ on August 4, 2026, that it was not in compliance with the exchange's minimum bid price requirement, and has until February 1, 2027, to regain compliance.
Jul 29, 2026, 00:00 UTC
Accuray Inc. signed a private placement of Series A Convertible Preferred Stock and warrants, raising $15 million in cash and converting $40 million of existing debt into equity.

ARAY

ACCURAY INC reported that Class II director Mika Nishimura departed following the expiration of her term.

ACCURAY INC appointed Richard A. Meier as a Class II director and member of its Compensation Committee.

Accuray stockholders approved all proposals presented at the company’s special meeting, enabling the company to complete previously announced transactions with TCW Asset Management Company.

Accuray Incorporated entered into agreements with Samsung HME America, Inc. (dba NeuroLogica Corp.) to pursue advanced volumetric imaging capabilities for the Accuray CyberKnife System.

Accuray Incorporated and RaySearch Laboratories AB entered into a definitive agreement for an expanded collaboration to integrate RayStation software with Accuray platforms and accelerate Accuray's online adaptive radiation therapy capabilities.

Accuray Inc reported Q4 2026 revenue of $100.9 million, down 21% year-over-year, with a net loss of $1.9 million and diluted EPS of -$0.02.

Accuray Incorporated announced two key executive leadership appointments to improve operational execution and profitability as part of its transformation plan.

Accuray Inc. received a notice from NASDAQ on August 4, 2026, that it was not in compliance with the exchange's minimum bid price requirement, and has until February 1, 2027, to regain compliance.

Accuray Inc. signed a private placement of Series A Convertible Preferred Stock and warrants, raising $15 million in cash and converting $40 million of existing debt into equity.